• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY MEGATRON?; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY MEGATRON?; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493942812350
Medical Device Problem Codes Break (1069); Deformation Due to Compressive Stress (2889)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/17/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that shaft break occurred.The 80% stenosed target lesion was located in the mildly tortuous and mildly calcified ostial circumflex artery.A 3.50 x 12mm synergy megatron? drug-eluting stent was advanced for treatment.However, during the procedure, the shaft was bent and the internal lumen was fractured, resulting in contrast leakage upon inflation.The procedure was completed with another megatron 3.5 16 mm des.There were no patient complications reported and the patient was fully recovered.
 
Additional Manufacturer Narrative
Good faith effort attempts were made to try and retrieve additional details regarding the reported event, but further information was unable to be obtained.
 
Additional Manufacturer Narrative
Good faith effort attempts were made to try and retrieve additional details regarding the reported event, but further information was unable to be obtained.Media review analysis: a photo was attached to the complaint record.A partial section of the hypotube was visible being inserted into the protective hoop.The photo showed evidence of a kink in the hypotube kinks were visible in the hypotube.
 
Event or Problem Description
It was reported that shaft break occurred.The 80% stenosed target lesion was located in the mildly tortuous and mildly calcified ostial circumflex artery.A 3.50 x 12mm synergy megatron? drug-eluting stent was advanced for treatment.However, during the procedure, the shaft was bent and the internal lumen was fractured, resulting in contrast leakage upon inflation.The procedure was completed with another megatron 3.5 16 mm des.There were no patient complications reported and the patient was fully recovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY MEGATRON?
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
mark mischke
4100 hamline ave n
arden hills, MN 55112
7634941632
MDR Report Key23678005
Report Number2124215-2025-87820
Device Sequence Number18742264
Product Code NIQ
UDI-Device Identifier08714729985570
UDI-Public(01)08714729985570(17)260902(10)34851264
Combination Product (Y/N)Y
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/21/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/02/2026
Device Model NumberH7493942812350
Device Catalogue NumberH7493942812350
Device Lot Number0034851264
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/17/2025
Supplement Date Received by Manufacturer12/11/2025
Initial Report FDA Received Date12/01/2025
Supplement Report FDA Received Date12/21/2025
Date Device Manufactured09/02/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age49 YR
Patient SexFemale
-
-